IMMUTEP LIMITEDIMMUTEP LIMITEDIMMUTEP LIMITED

IMMUTEP LIMITED

No trades
See on Supercharts
Market capitalization
‪445.81 M‬AUD
−0.040AUD
‪−39.90 M‬AUD
‪1.06 B‬
Beta (1Y)
1.09

About IMMUTEP LIMITED

CEO
Marc Voigt
Headquarters
Sydney
Founded
1987
ISIN
AU000000IMM6
FIGI
BBG000BLY887
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987, and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IMM is 0.35 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMMUTEP LIMITED stocks are traded under the ticker IMM.
IMMUTEP LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for IMMUTEP LIMITED has a max estimate of 1.25 AUD and a min estimate of 0.65 AUD.
IMM earnings for the last quarter are −0.02 AUD whereas the estimation was −0.02 AUD which accounts for 0.09% surprise. Estimated earnings for the next quarter are −0.02 AUD. See more details about IMMUTEP LIMITED earnings.
IMMUTEP LIMITED revenue for the last quarter amounts to ‪1.91 M‬ AUD despite the estimated figure of ‪3.23 M‬ AUD. In the next quarter revenue is expected to reach ‪2.75 M‬ AUD.
Yes, you can track IMMUTEP LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, IMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUTEP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
IMM reached its all-time high on Mar 27, 2000 with the price of 22.45 AUD, and its all-time low was 0.05 AUD and was reached on Sep 18, 2008.
See other stocks reaching their highest and lowest prices.